Genprex Selects Andelyn Biosciences for Scale-Up Manufacturing of Diabetes Gene Therapy
Genprex’s gene therapy candidate aims to restore insulin-producing function in diabetes by delivering Pdx1 and MafA genes to the pancreas using an AAV vector.
Insulin-producing Beta Cells | 03/09/2026 | By Akanki
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy